The Buzz: An Interview with Donald A. Deieso, PhD, WIRB-Copernicus Group

Danny Al-Faruque interviews Donald A. Deieso, PhD, Chairman & CEO, WIRB-Copernicus Group, on behalf of FDAnews.com

To read this article in its entirety, please login to FDAnews.com, by clicking here.

Publication: Washington Drug Letter, FDAnews.com